Abstract
The muscarinic M2 receptor contains an orthosteric and an allosteric site. Binding of an allosteric agent may induce a shift α of the equilibrium dissociation constant K Dof a radioligand for the orthosteric site. According to the cooperativity model, the K A of alloster binding is expected to be shifted to an identical extent depending on whether the orthosteric site is occupied by the orthoster or not. Here, the novel radioalloster [3H]dimethyl-W84 (N,N′-bis[3-(1,3-dihydro-1,3-dioxo-4-methyl-2H-isoindol-2-yl)propyl]-N,N,N′,N′-tetramethyl-1,6-hexanediaminium diiodide) was applied to directly measure theK A shift induced for the prototype allosteric modulator gallamine by binding ofN-methylscopolamine (NMS) to the orthosteric site of porcine heart M2 receptors (4 mM Na2HPO4, 1 mM KH2PO4, pH 7.4; 23°C; data are means ± S.E.). First, in the common way, the concentration-dependent inhibition by gallamine of [3H]NMS equilibrium binding was measured and analyzed using the cooperativity model, which yielded for the affinity of gallamine binding at free receptors a pK A= 8.35 ± 0.09 and a cooperativity factor α = 46 (n = 5). The dissociation constant for gallamine binding at NMS-occupied receptors was predicted as p(α · K A) = 6.69. Labeling of the allosteric site by [3H]dimethyl-W84 allowed the measure of competitive displacement curves for gallamine. TheK i for gallamine at free receptors amounted to pK i,−NMS = 8.27 ± 0.39 (n = 5), which is in line with the prediction of the cooperativtiy model. In the presence of 1 μM NMS, to occupy the orthosteric site, gallamine displaced [3H]dimethyl-W84 with pK i,+NMS = 6.60 ± 0.19 (n = 3). Thus, the NMS-induced pK i shift amounted to 47, which matches the predicted value of α = 46. These results validate the cooperativity model.
Footnotes
- Received May 17, 1999.
- Accepted July 29, 1999.
-
Send reprint requests to: Klaus Mohr, Department of Pharmacology and Toxicology, Institute of Pharmacy, University of Bonn, An der Immenburg 4, D-53121, Bonn, Germany. E-mail:K.Mohr{at}uni-bonn.de
-
This work was supported by the Deutsche Forschungsgemeinschaft.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|